Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460

Clinical Cancer Research

Volumn 8, Issue 2, 2002, Pages 596-606

  Huisman, Cynthia ^a   Ferreira, Carlos G ^a   Bröker, Linda E ^a   Rodriguez, Jose A ^a   Smit, Egbert F ^a   Postmus, Pieter E ^a   Kruyt, Frank A E ^a   Giaccone, Giuseppe ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 8; CASPASE INHIBITOR; CELL RECEPTOR; CYTOCHROME C; CYTOKINE; FAS ANTIGEN; LIPOCORTIN 5; N BENZYLOXYCARBONYLVALYLALANYLASPARTYLFLUOROMETHYLKETONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; PROPIDIUM IODIDE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; TRIPEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

AMINO ACID CHLOROMETHYL KETONES; ANNEXIN A5; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; ARABIDOPSIS PROTEINS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 8; CASPASE 9; CASPASES; CELL DEATH; CELL LINE; CELL SURVIVAL; CYTOCHROME C GROUP; CYTOSOL; DNA DAMAGE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; ENZYME INHIBITORS; FATTY ACID DESATURASES; GENES, DOMINANT; HUMANS; LUNG NEOPLASMS; MITOCHONDRIA; MODELS, BIOLOGICAL; PACLITAXEL; POLY(ADP-RIBOSE) POLYMERASES; PROPIDIUM; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; SPECTROMETRY, FLUORESCENCE; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036184739     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Apoptosis in cancer therapy: Crossing the threshold
2. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations
3. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents
4. The effect of antimicrotubule agents on signal transduction pathways of apoptosis: A review
5. Paclitaxel-induced cell death: Where the cell cycle and apoptosis come together
6. Modulation of mitogen-activated protein kinases and phosphorylation of Bcl-2 by vinblastine represent persistent forms of normal fluctuations at G2-MI
7. Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis
8. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53
9. Taxol-induced cell cycle arrest and apoptosis: Dose-response relationship in lung cancer cells of different wild-type p53 status and under isogenic condition
10. p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma
11. Molecular effects of paclitaxel: Myths and reality (a critical review)
12. Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery
13. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis
14. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis
15. Apoptotic pathways: Paper wraps stone blunts scissors
16. Apoptosis control by death and decoy receptors
17. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain
18. The TRAIL discussion: It is FADD and caspase-8!
19. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
20. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
21. Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in non-small cell lung cancer cells
22. Drug-induced apoptosis in lung cancer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway
23. Disruption of cell adhesion and caspase-mediated proteolysis of β- and γ-catenins and APC protein in paclitaxel-induced apoptosis
24. Cytotoxic drugs and the CD95 pathway
25. Safety and antitumor activity of recombinant soluble Apo2 ligand
26. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family
27. Identification and characterization of a new member of the TNF family that induces apoptosis
28. Cell death beyond apoptosis
29. Bcl-2 overexpression is associated with resistance to dexamethasone, but not melphalan, in multiple myeloma cells
30. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells
31. Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells
32. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis
33. High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells
34. Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells
35. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally
36. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis
37. Caspase-8 activation independent of CD95/CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4)
38. Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3
39. Apoptosis is critical for drug response in vivo
40. Apoptosis: Mediator of mode of cell killing by anticancer agents?
41. Apoptosis without caspases: An inefficient molecular guillotine?
42. Four deaths and a funeral: From caspases to alternative mechanisms
43. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death
44. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2
45. More than one way to die: Apoptosis, necrosis and reactive oxygen damage
46. Cathepsins as effector proteases in hepatocyte apoptosis
47. Bax cleavage is mediated by calpain during drug-induced apoptosis
48. Caspase-dependent activation of calpain during drug-induced apoptosis
49. Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity
50. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex
51. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer
52. bcl-2 protein in non-small-cell lung carcinoma
53. Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients
54. Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients
55. Sequence dependent effect of paclitaxel on gemcitabine metabolism in relation to cell cycle and cytotoxicity in non-small-cell lung cancer cell lines
56. Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine